Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Blood safety in Canada On this page How Health Canada regulates blood and plasma Canada's blood operators Donor deferrals Deferral for men who have sex with men Recent changes to screening criteria for men who have sex with men How Health Canada regulates blood and plasma Health…
Qualifying notice for Gardasil 9 Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney’s Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-e170006 Control #: 251509 [employee name removed] [employee title removed] Merck Canada Inc.…
Qualifying notice for Rybrevant Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney’s Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-e245921 Control #: 254440 [employee name removed] [employee title removed] Janssen Inc. 19…
Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in clinical trials, or as a drug accessed through the Special Access Program (SAP) May 6, 2022 Our file number: 22-105312-974 Purpose Health Canada is aware of the growing interest in the…
Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) May 16, 2022 Our file number: 22-105587-718 The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of "brimonidine or its salts" on the Prescription Drug List…
Notice: Multiple additions to the Prescription Drug List (PDL) June 17, 2022 Our file number: 22-107199-26 The purpose of this Notice of Amendment is to notify about the additions of amivantamab, belumosudil, bimekizumab, cariprazine, cilgavimab, lumasiran, pegvaliase and…
Qualifying notice for Thiotepa for Injection USP Therapeutic Products Directorate Holland Cross, Tower "B" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa ON K1A 0K9 Dossier ID: e238038 Control #: 238038 [name of employee removed] [title of employee removed] [name of…
Notice of Intent to Amend the Prescription Drug List (PDL): Betaine July 6, 2022 Our file number: 21-108009-981 The purpose of this Notice of Intent to Amend is to announce that Health Canada will remove "Betaine or its salts" from the Veterinary part of the Prescription Drug…
Notice of Amendment: Addition of Metamizole (Dipyrone) to the Prescription Drug List (PDL) Date: July 18, 2022 Our file number: 22-108325-965 The purpose of this Notice of Amendment is to announce that metamizole (also known as 'dipyrone') has been added to the veterinary part of…
Fees for Drug Master Files Fees for the filing of Master File transactions used in support of drug submissions and DIN applications for human and/or veterinary use or Clinical Trial Applications (CTAs) Item Fee Category Fee as of April 1, 2025 Fee as of April 1, 2026 1 New Master…
Early release: coverage and features are still expanding.
